A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safely of idelalisib on eninhination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia Meeting Abstract

  

Authors:	Salles, G. A.; Lamanna, N.; Amin, B. R.; Boccia, R. V.; Gabrali, N. Y.; Zaydan, M. A. A.; Wong, M.; Adewoye, A. H.; Ghia, P.
Abstract Title:	A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safely of idelalisib on eninhination with bendamustine and rituximab for previously untreated chronic lymphocytic leukemia
Meeting Title:	50th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	32
Issue:	15 Suppl.
Meeting Dates:	2014 May 30-Jun 3
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2014-05-20
Language:	English
ACCESSION:	WOS:000358613202187
PROVIDER:	wos
Notes:	Meeting Abstract: TPS7123 -- Source: Wos